Clinical Evaluation Reports (CER) and Post-Market Surveillance (PMS) Services in Poland

In the highly regulated European landscape, manufacturers of chemical solutions, water treatment technologies, and medical devices must navigate rigorous compliance frameworks to access and maintain market placement. At Water Chemicals Solution (Alkemist), we specialize in providing authoritative, audit-ready Clinical Evaluation Reports (CER) and Post-Market Surveillance (PMS) plans tailored specifically for the Polish market. Whether your technology interfaces with water purification systems, specialized chemical disinfection, or clinical-grade fluid management, our regulatory experts ensure seamless compliance with Polish and European authorities.

1. Applicable Regulations in POLAND

Operating within Poland requires strict adherence to both harmonized European Union regulations and specific national legislations enforced by local Polish authorities. The primary regulatory framework governing medical devices, specialized water treatment devices (such as dialysis water systems), and associated chemical solutions includes:

• Regulation (EU) 2017/745 (MDR): The overarching European Medical Device Regulation requiring comprehensive clinical evaluation (CER) and active, systematic post-market surveillance (PMS) for all certified devices.
• The Polish Act on Medical Devices (Ustawa o wyrobach medycznych): The local legislation aligning Polish national law with the MDR, governing the registration, advertising, and monitoring of devices on the Polish market.
• URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych): The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland, which acts as the national competent authority reviewing technical dossiers, CERs, and PMS data.
• Biocidal Products Regulation (BPR, Regulation (EU) No 528/2012): For chemical solutions that cross the boundary between medical device disinfectants and biocides, requiring aligned safety assessments and localized hazard phrasing.

2. What We Deliver for POLAND

Water Chemicals Solution (Alkemist) provides a turn-key compliance pathway for companies introducing or maintaining products in the Polish market. We deliver technically robust, fully compliant documentation designed to pass URPL and Notified Body scrutiny with ease.

• Fast Turnaround Times: Our streamlined data collection and drafting methodologies ensure that your CERs and PMS plans are completed rapidly, preventing costly delays in product launches or market registrations.
• Localized Language Variants: Polish regulatory submissions frequently demand documentation in the national language. We provide professional translation and localization of technical files, CER summaries, and PMS plans into precise, legally accepted Polish.
• Export-Ready Files: All deliverables are provided in highly structured, export-ready digital formats that integrate seamlessly with your existing Quality Management System (QMS) and conform to electronic submission standards.
• Comprehensive CER & PMS Integration: We design active feedback loops where Post-Market Clinical Follow-up (PMCF) and PMS data feed directly back into your CER, ensuring continuous compliance throughout the product lifecycle.

3. Local Challenges We Solve

Expanding or maintaining a chemical or medical device portfolio in Poland presents unique local administrative and linguistic hurdles. Alkemist acts as your local regulatory anchor, solving critical bottlenecks such as:

• Customs and Import Delays: Shipments of specialized water treatment chemicals and device components are frequently held at Polish customs due to incomplete regulatory declarations. We align your technical files with URPL requirements to ensure smooth customs clearance.
• Hazard Phrasing Differences (GHS/CLP vs. MDR): Reconciling chemical safety data sheets (SDS) with medical device clinical evaluations is notoriously complex. We ensure that local Polish hazard phrases, precautionary statements, and signal words strictly align with both ECHA (European Chemicals Agency) and URPL directives.
• Notified Body Scrutiny on Equivalence: Demonstrating technical, biological, and clinical equivalence under the MDR has become exceptionally difficult. Our clinical writers possess the scientific expertise to establish robust equivalence arguments acceptable to European regulators operating in Poland.
• Linguistic Accuracy in Clinical Summaries: Technical nuances can easily be lost in translation, leading to regulatory rejection. Our bilingual Polish-English toxicologists and medical writers ensure absolute precision in chemical nomenclature and clinical data representation.

4. Start Your Request

Secure your market position in Poland with expert-drafted Clinical Evaluation Reports and Post-Market Surveillance plans. Partner with Water Chemicals Solution (Alkemist) to de-risk your compliance journey, eliminate regulatory delays, and ensure continuous market access.

Contact our regulatory compliance team today to discuss your project scope, receive a customized quotation, or request a review of your current technical file. Reach out directly to initiate your compliance pathway:

Email: admin@alkemist.org